IRCT20200509047366N1尚未招募1 期
Assessment of adding low dose pulmonary radiotherapy to the national protocol of COVID-19 management: A pilot trial.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 60 years 至 no limit（—）
- 性别
- All
入选标准
- •Confirmed COVID-19 diagnosis ( PCR or serologic)
- •Presence of pulmonary involvement ( defined by P/F ratio or NIV need)
- •Less than 3 days since the onset of ARDS
- •Age > 60 years
- •? IL-6 ( if available)
排除标准
- •Lack of informed consent
- •Inability to transfer to the radiation unit
- •Hemodynamic instability
- •Septic shock and organ dysfunction
- •Severe ARDS P/F ratio = 100 mmHg
- •History of cardiac failure
- •Contraindications to radiation
研究者
相似试验
尚未招募
2 期
A clinical trial to study the impact of low dose radiation to the lungs in patients with moderate COVID Pneumonia.CTRI/2021/06/033912All India Institute of Medical Sciences Patna
进行中（未招募）
2 期
A clinical trial to prove the benefit of low dose X-rays to lungs in treating COVID-19 diseaseCTRI/2021/06/034001Sri Venkateswara Institute of Medical Sciences
已完成
2 期
ow dose whole lung irradiation for treatment of COVID-19 pneumoniaIRCT20170211032494N3Tehran University of Medical Sciences10
已完成
不适用
Results of stereotactic body radiotherapy for lung and liver.lung and liver tumorJPRN-UMIN000034389Asahi University60
已完成
2 期
Phase II study of thoracic radiotherapy concurrently combined with cisplatin and vinorelbine chemotherapy followed by sequential therapy with TS-1 for inoperable locally advanced non-small cell lung cancerJPRN-UMIN000002381ational Hospital Study Group for Lung Cancer65